Neurocognitive Battery Feasible in 3-Year-Olds During Leukemia Treatment
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.
Sameera Ramjan, from Memorial Sloan Kettering Cancer Center in New York City, and colleagues offered patients enrolled in the Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents participation in an optional neurocognitive study assessing longitudinal changes in neurocognitive function. The analysis included 3- and 4-year-old patients enrolled in the study.
The researchers found that 3-year-old patients did not differ from 4-year-olds in terms of their ability to perform or complete the brief Cogstate battery assessing psychomotor function (detection) and attention (identification). These findings persisted at four time-point assessments, through 52 weeks after diagnosis.
"This report demonstrates that computerized testing, such as Cogstate, can be successfully administered to 3-year-old patients who are undergoing treatment for acute lymphoblastic leukemia, thereby capturing serial test data on a vulnerable patient population that, in prior studies, have demonstrated worse neurocognitive deficits," the authors write. "Consequently, changing future study inclusion criteria to include patients diagnosed at the age of 3 years will ultimately serve to improve our understanding of at-risk patients and the neurocognitive trajectory of this age group both during treatment as well as into survivorship, thereby leading to the development of early interventions."
One author disclosed ties to the pharmaceutical industry; two authors disclosed ties to Cogstate.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Parent-Reported Firearm Storage Poor Estimator of Teen Perceived Access
MONDAY, June 16, 2025 -- Parent-reported firearm storage seems to be a poor estimator of teen perceived firearm access, according to a study published online June 10 in JAMA...
CT Colonography Cost-Effective, Clinically Effective for CRC Screening
MONDAY, June 16, 2025 -- Computed tomography colonography (CTC) is cost-effective and clinically effective for colorectal cancer (CRC) screening, according to a study published...
Global Incidence Rate of Rheumatoid Arthritis Increased From 1990 to 2021
MONDAY, June 16, 2025 -- The incidence rate of rheumatoid arthritis (RA) increased globally from 1990 to 2021, with the heaviest burden born by regions with a high...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.